Cargando…
Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop
Tumor immunology has changed the landscape of cancer treatment. Yet, not all patients benefit as cancer immune responsiveness (CIR) remains a limitation in a considerable proportion of cases. The multifactorial determinants of CIR include the genetic makeup of the patient, the genomic instability ce...
Ejemplares similares
-
Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop
por: Bedognetti, Davide, et al.
Publicado: (2019) -
Preamble to the 2015 SITC immunotherapy biomarkers taskforce
por: Butterfield, Lisa H, et al.
Publicado: (2015) -
SITC 2018 workshop report: Immuno-Oncology Biomarkers: State of the Art
por: Butterfield, Lisa H., et al.
Publicado: (2018) -
Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force
por: Butterfield, Lisa H, et al.
Publicado: (2010) -
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
por: DeNardo, David G, et al.
Publicado: (2007)